cephalosporin c has been researched along with Psoriasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hino, R; Kabashima-Kubo, R; Nakamura, M; Sawada, Y | 1 |
| Bergman, R; Friedman-Birnbaum, R; Sprecher, E | 1 |
2 other study(ies) available for cephalosporin c and Psoriasis
| Article | Year |
|---|---|
Fatal case of toxic epidermal necrolysis caused by cefozopran and associated with psoriasis.
Topics: Aged; Anti-Bacterial Agents; Cefozopran; Cephalosporins; Disseminated Intravascular Coagulation; Fatal Outcome; Female; Humans; Psoriasis; Pyelonephritis; Sepsis; Shock, Septic; Skin; Stevens-Johnson Syndrome; Ultraviolet Therapy | 2014 |
Cyclosporine treatment of psoriatic erythroderma complicated by bacterial sepsis.
Topics: Acitretin; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Cyclosporine; Dermatitis, Exfoliative; Dermatologic Agents; Humans; Immunosuppressive Agents; Keratolytic Agents; Male; Middle Aged; Psoriasis; Sepsis; Staphylococcal Infections; Streptococcal Infections; Vancomycin | 1999 |